Cargando…
非小细胞肺癌PD-1/PD-L1的表达与EGFR突变相关性研究
BACKGROUND AND OBJECTIVE: The treatment mode of lung cancer is epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) as a first-line treatment for patients with EGFR mutant in non-small cell lung cancer (NSCLC). At the same time programmed death receptor 1 (PD-1) and its programmed...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503982/ https://www.ncbi.nlm.nih.gov/pubmed/34455737 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.31 |